Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness

JAMA Pub Date : 2025-02-19 DOI:10.1001/jama.2024.27922
Ryan D. Assaf, Meghan D. Morris, Elana R. Straus, Priest Martinez, Morgan M. Philbin, Margot Kushel
{"title":"Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness","authors":"Ryan D. Assaf, Meghan D. Morris, Elana R. Straus, Priest Martinez, Morgan M. Philbin, Margot Kushel","doi":"10.1001/jama.2024.27922","DOIUrl":null,"url":null,"abstract":"ImportanceThe lack of representative research on homelessness risks mischaracterizing and misrepresenting the prevalence of illicit substance use.ObjectiveTo estimate the population prevalence and patterns of illicit substance use, treatment, nonfatal overdose, and naloxone possession among people experiencing homelessness in 1 US state.Design, Setting, and ParticipantsThis representative survey study of adults experiencing homelessness from October 2021 to November 2022 in 8 California counties used multistaged probability-based sampling and respondent-driven sampling. Eligible individuals were 18 years or older and met the federal definition of homelessness.Main Outcomes and MeasuresThe primary outcome measures included lifetime and past–6-month illicit substance use and substance type (methamphetamine, nonprescription opioids, or cocaine). Lifetime and current substance use treatment, unmet treatment need, types of treatments received, nonfatal overdose (lifetime and current episode of homelessness), and current possession of naloxone were measured. Population prevalence estimates with 95% Wald CIs were calculated using survey replicate weights.ResultsOf 3865 individuals approached, 3042 (79%) participated and an additional 158 participants were recruited through respondent-driven sampling. Among 3200 participants, the mean age was 46.1 (95% CI, 45.3-46.9) years, 67.3% (95% CI, 65.2%-69.3%) were cisgender male, and there were similar proportions of Black and African American, Hispanic and Latine, and White participants. Overall, an estimated 65.3% (95% CI, 62.2%-68.4%) of participants used illicit drugs regularly (≥3 times per week) in their lifetime; 41.6% (95% CI, 39.4%-43.8%) began using regularly before their first episode of homelessness and 23.2% (95% CI, 20.5%-25.9%) began using regularly after. In the past 6 months, an estimated 37.1% (95% CI, 32.9%-41.3%) of participants reported regular use of any drug; 33.1% (95% CI, 29.4%-36.7%) reported use of methamphetamines, 10.4% (95% CI, 7.9%-12.9%) reported use of opioids, and 3.2% (95% CI, 1.8%-4.6%) reported use of cocaine. In their lifetime, an estimated 25.6% (95% CI, 22.8%-28.3%) injected drugs and 11.8% (95% CI, 9.8%-13.8%) injected drugs in the past 6 months. Among those with any regular lifetime use, an estimated 6.7% (95% CI, 3.8%-9.5%) of participants were currently receiving treatment. Of those with any regular use in the last 6 months, an estimated 21.2% (95% CI, 17.9%-24.5%) reported currently wanting but not receiving treatment. An estimated 19.6% (95% CI, 17.4%-21.8%) of participants had a nonfatal overdose in their lifetime and 24.9% (95% CI, 21.3%-28.5%) currently possessed naloxone.Conclusion and RelevanceIn a representative study of adults experiencing homelessness in California, there was a high proportion of current drug use, history of overdose, and unmet need for treatment. Improving access to treatment tailored to the needs of people experiencing homelessness could improve outcomes.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jama.2024.27922","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ImportanceThe lack of representative research on homelessness risks mischaracterizing and misrepresenting the prevalence of illicit substance use.ObjectiveTo estimate the population prevalence and patterns of illicit substance use, treatment, nonfatal overdose, and naloxone possession among people experiencing homelessness in 1 US state.Design, Setting, and ParticipantsThis representative survey study of adults experiencing homelessness from October 2021 to November 2022 in 8 California counties used multistaged probability-based sampling and respondent-driven sampling. Eligible individuals were 18 years or older and met the federal definition of homelessness.Main Outcomes and MeasuresThe primary outcome measures included lifetime and past–6-month illicit substance use and substance type (methamphetamine, nonprescription opioids, or cocaine). Lifetime and current substance use treatment, unmet treatment need, types of treatments received, nonfatal overdose (lifetime and current episode of homelessness), and current possession of naloxone were measured. Population prevalence estimates with 95% Wald CIs were calculated using survey replicate weights.ResultsOf 3865 individuals approached, 3042 (79%) participated and an additional 158 participants were recruited through respondent-driven sampling. Among 3200 participants, the mean age was 46.1 (95% CI, 45.3-46.9) years, 67.3% (95% CI, 65.2%-69.3%) were cisgender male, and there were similar proportions of Black and African American, Hispanic and Latine, and White participants. Overall, an estimated 65.3% (95% CI, 62.2%-68.4%) of participants used illicit drugs regularly (≥3 times per week) in their lifetime; 41.6% (95% CI, 39.4%-43.8%) began using regularly before their first episode of homelessness and 23.2% (95% CI, 20.5%-25.9%) began using regularly after. In the past 6 months, an estimated 37.1% (95% CI, 32.9%-41.3%) of participants reported regular use of any drug; 33.1% (95% CI, 29.4%-36.7%) reported use of methamphetamines, 10.4% (95% CI, 7.9%-12.9%) reported use of opioids, and 3.2% (95% CI, 1.8%-4.6%) reported use of cocaine. In their lifetime, an estimated 25.6% (95% CI, 22.8%-28.3%) injected drugs and 11.8% (95% CI, 9.8%-13.8%) injected drugs in the past 6 months. Among those with any regular lifetime use, an estimated 6.7% (95% CI, 3.8%-9.5%) of participants were currently receiving treatment. Of those with any regular use in the last 6 months, an estimated 21.2% (95% CI, 17.9%-24.5%) reported currently wanting but not receiving treatment. An estimated 19.6% (95% CI, 17.4%-21.8%) of participants had a nonfatal overdose in their lifetime and 24.9% (95% CI, 21.3%-28.5%) currently possessed naloxone.Conclusion and RelevanceIn a representative study of adults experiencing homelessness in California, there was a high proportion of current drug use, history of overdose, and unmet need for treatment. Improving access to treatment tailored to the needs of people experiencing homelessness could improve outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无家可归的成年人的非法药物使用和治疗途径
缺乏关于无家可归问题的代表性研究可能会对非法药物使用的普遍程度进行错误的描述和歪曲。目的评估美国1个州无家可归者中非法药物使用、治疗、非致命性过量和纳洛酮持有的人口流行率和模式。设计、环境和参与者这项代表性的调查研究对2021年10月至2022年11月在加州8个县经历无家可归的成年人进行了多阶段基于概率的抽样和受访者驱动的抽样。符合条件的个人必须年满18岁,并且符合联邦对无家可归者的定义。主要结局和措施主要结局措施包括终生和过去6个月的非法药物使用和物质类型(甲基苯丙胺,非处方阿片类药物或可卡因)。测量了终生和当前药物使用治疗、未满足的治疗需求、接受的治疗类型、非致命性过量(终生和当前无家可归事件)和当前纳洛酮的持有情况。使用调查重复权计算具有95% Wald ci的人群患病率估计值。结果在3865个人中,3042人(79%)参与了调查,另外158人通过受访者驱动的抽样方式被招募。在3200名参与者中,平均年龄为46.1岁(95% CI, 45.3-46.9), 67.3% (95% CI, 65.2%-69.3%)为顺性男性,黑人和非裔美国人、西班牙裔和拉丁裔以及白人参与者的比例相似。总体而言,估计65.3% (95% CI, 62.2%-68.4%)的参与者在其一生中经常使用非法药物(每周≥3次);41.6% (95% CI, 39.4%-43.8%)的人在第一次无家可归之前开始定期吸毒,23.2% (95% CI, 20.5%-25.9%)的人在第一次无家可归之后开始定期吸毒。在过去的6个月里,估计有37.1% (95% CI, 32.9%-41.3%)的参与者报告经常使用任何药物;33.1% (95% CI, 29.4%-36.7%)报告使用甲基苯丙胺,10.4% (95% CI, 7.9%-12.9%)报告使用阿片类药物,3.2% (95% CI, 1.8%-4.6%)报告使用可卡因。在他们的一生中,估计有25.6% (95% CI, 22.8%-28.3%)的人注射过毒品,11.8% (95% CI, 9.8%-13.8%)的人在过去6个月内注射过毒品。在终身定期使用的参与者中,估计有6.7% (95% CI, 3.8%-9.5%)的参与者目前正在接受治疗。在过去6个月内有任何常规使用的人中,估计有21.2% (95% CI, 17.9%-24.5%)报告目前想要但未接受治疗。估计有19.6% (95% CI, 17.4%-21.8%)的参与者在其一生中有非致命的过量服用,24.9% (95% CI, 21.3%-28.5%)的参与者目前拥有纳洛酮。结论和相关性在一项针对加州无家可归的成年人的代表性研究中,有很高比例的人目前使用药物,有过量用药史,并且未满足治疗需求。根据无家可归者的需要,改善获得治疗的机会可以改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Primary Biliary Cholangitis and Prognostic Models-Reply. Toward Greater Transparency at the FDA-Now Is the Time to Act. Primary Biliary Cholangitis and Prognostic Models. Poetry and Service Learning in Medicine. Restrictive vs Liberal Physical Restraint Strategies in Critically Ill Patients: Research Summary.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1